Menopause Symptoms: The Complete List (All 34+)

You've been exhausted for months. Your sleep is garbage. You gained 12 pounds and you haven't changed your diet. You're crying at commercials and then furious two minutes later. Your doctor ran labs and said everything was "normal."

It's not nothing. Your hormones are changing, and when estrogen levels start swinging and eventually declining, your body feels it in ways that most people — and honestly, most doctors — aren't prepared to explain clearly.

This article covers all 34+ menopause symptoms across every system in your body, tells you which ones actually respond to treatment, and addresses the safety controversy that's been scaring women away from effective care for over two decades.

---

What Actually Counts as a Menopause Symptom?

Menopause is defined as 12 consecutive months without a period, typically occurring between ages 45 and 55 in the US. The average American woman reaches menopause at 51 (Ahuja, 2016). But the real action happens before that. Perimenopause, the transition phase that can start 4 to 10 years earlier and involves wildly fluctuating estrogen, progesterone, and testosterone.

The symptoms people call "menopause symptoms" are mostly perimenopause symptoms. And they're not just about heat and mood swings. Estrogen receptors are distributed throughout your entire body: your brain, heart, skin, gut, vagina, joints, and bladder. When estrogen drops, none of those systems are unaffected.

The Menopause Rating Scale, validated across 9 countries in a large multinational survey (Heinemann et al., 2004), groups symptoms into three categories: somatic (body-based), psychological, and urogenital. The full clinical picture is much wider than those three buckets suggest.

---

Vasomotor Symptoms: Hot Flashes and Night Sweats

Hot flashes are the most recognized menopause symptom, and they're also among the most studied. The Study of Women's Health Across the Nation (SWAN), one of the largest and most ethnically diverse longitudinal studies of the menopausal transition, found that vasomotor symptoms affect the majority of women going through menopause, with meaningful variation by race, ethnicity, and weight (Thurston and Joffe, 2011).

Hot flashes hit when your brain's hypothalamus misreads your body temperature and triggers a heat-dissipation response. You get a sudden wave of heat, often from the chest up. Your skin flushes. You sweat. Some women feel their heart pounding during the episode. Then, as the sweat evaporates, you can feel suddenly cold.

Night sweats are the nocturnal version. You wake up drenched — or your partner notices before you do. The disrupted sleep compounds every other symptom, especially mood and cognitive issues.

How long does this last? The Melbourne Women's Midlife Health Project tracked 438 women for 13 years. The mean duration of bothersome vasomotor symptoms for women who never used hormone therapy was 5.2 years (Col et al., 2009). Some women experience symptoms for 10 years or more. Regular exercise was the only factor associated with shorter duration.

A 2021 global cross-sectional survey of postmenopausal women in the US, Europe, and Japan found that moderate-to-severe vasomotor symptoms affect 34% of US postmenopausal women; 54% of eligible women are HRT-averse, even though hormones are the most effective treatment available (Nappi et al., 2021).

Vasomotor symptoms: direct HRT benefit. Estrogen therapy remains the most effective treatment for hot flashes and night sweats. A randomized trial comparing low-dose oral estradiol (0.5 mg/day) and venlafaxine extended release (75 mg/day) in 339 perimenopausal and postmenopausal women found that estradiol significantly reduced vasomotor symptom frequency; venlafaxine also worked but was less effective (Joffe et al., 2014).

---

Menopause Signs That Hit Your Sleep and Fatigue

Sleep problems during menopause operate on multiple levels. Night sweats wake you up. But even without them, falling asleep gets harder, staying asleep gets harder, and the quality of what little sleep you do get deteriorates.

Insomnia is one of the most commonly reported symptoms in the global MENQOL survey, along with fatigue, joint aches, and hot flashes (Nappi et al., 2021). The combined HRT trial published in the BMJ (Welton et al., 2008) showed significant improvements in sleep problems among women taking combined estrogen-progesterone therapy versus placebo, alongside improvements in vasomotor symptoms and sexual function.

Fatigue follows directly from sleep disruption, but also has an independent hormonal component. Estrogen plays a role in mitochondrial energy production. Women in the MENQOL survey were slightly more likely to report "feeling tired or worn out" (74%) than to report hot flashes (68%), which tells you something about how this constellation of symptoms actually feels day-to-day.

Restless legs syndrome and palpitations (a racing or irregular heartbeat sensation) are less discussed but genuinely common. The palpitations are related to the same hypothalamic thermoregulatory disruption that drives hot flashes, not a cardiac event in most cases, though it warrants evaluation.

---

Urogenital Symptoms: What No One Tells You

This is the category women are least likely to bring up with their doctors — and doctors are least likely to ask about. The gap is enormous.

An international survey of 4,246 women ages 55-65 found that 39% of postmenopausal women had experienced vaginal atrophy, but 63% of those who had symptoms had never been prescribed treatment for the condition. Of those who had been treated, 67% reported positive effects (Nappi and Kokot-Kierepa, 2010). That's a massive treatment gap for something treatable.

Urogenital symptoms include:

Vaginal dryness: the lining of the vagina thins and loses moisture as estrogen drops. This causes discomfort, pain with intercourse (dyspareunia), and can lead to small tears or irritation.

Vaginal atrophy (now called genitourinary syndrome of menopause, or GSM): a more significant change in the tissue of the vagina and vulva, including loss of elasticity and altered pH.

Urinary urgency: the sudden, strong need to urinate that's hard to suppress. Estrogen receptors in the bladder and urethra affect sphincter control.

Urinary incontinence: particularly stress incontinence (leaking when you sneeze, cough, or laugh) and urge incontinence. Not because of age. Because of estrogen.

Recurrent urinary tract infections (UTIs): lower estrogen raises vaginal pH, creating an environment more hospitable to the bacteria that cause UTIs.

Painful intercourse: a direct consequence of vaginal dryness and atrophy. This is both a physical symptom and a driver of sexual avoidance, which can strain relationships without either partner fully understanding what's happening.

Decreased libido: related partly to testosterone decline, partly to the pain and discomfort of intercourse, and partly to the mood and energy disruption happening in parallel.

Local (vaginal) estrogen therapy and testosterone can address most urogenital symptoms directly. Crandall et al. (2023) confirms in JAMA that estrogen is first-line therapy for both vasomotor symptoms and GSM, and that local estrogen is appropriate for women who can't or don't want to use systemic HRT.

---

Psychological Symptoms: Mood, Anxiety, and Depression

If you've noticed you're angrier than you used to be, anxious about things that didn't bother you before, or crying more than makes sense given your circumstances. This isn't a personality change. It's a neurological and hormonal change.

Estrogen has significant effects on serotonin and dopamine pathways. When it fluctuates, your emotional regulation fluctuates with it.

A prospective cohort study of 436 women (Freeman et al., 2004) followed for four years found an increased likelihood of depressive symptoms during the menopausal transition, even after controlling for history of depression, severe PMS, poor sleep, age, race, and employment status. The likelihood decreased after menopause, suggesting the transition itself is the vulnerable period.

Common psychological symptoms include:

Mood swings: rapid emotional shifts that feel out of proportion to circumstances. Not a character flaw. Estrogen fluctuations disrupt the limbic system.

Irritability and rage: specifically what women describe as "flipping out over nothing" and then feeling terrible about it. The amygdala becomes less regulated.

Anxiety: new or worsening anxiety, sometimes with physical symptoms like racing heart or chest tightness that get mistaken for cardiac issues.

Depression: clinical depression rates rise during perimenopause. Women with a history of PMS or postpartum depression are at higher risk.

Emotional lability: crying unpredictably, feeling emotionally "thin-skinned," or experiencing emotions more intensely than usual.

These symptoms often respond to HRT, particularly if estrogen is the primary driver. For women who can't use hormones, paroxetine (an SSRI FDA-approved for vasomotor symptoms) and venlafaxine have evidence behind them. Citalopram showed improvement in insomnia specifically in a 9-month placebo-controlled trial (Suvanto-Luukkonen et al., 2005), though the overall effect on hot flashes and mood wasn't statistically significant versus placebo.

---

Menopause Brain Fog: The Cognitive Symptoms

"I used to be sharp. Now I walk into a room and forget why I'm there six times a day."

This is one of the most distressing symptoms for women who've built careers on their intellectual ability. And it's real — not anxiety, not catastrophizing.

Brain fog: difficulty concentrating, processing information more slowly, feeling mentally "fuzzy."

Memory lapses: particularly short-term memory and word retrieval. You know the word. It just won't come. You said something five minutes ago and can't recall it.

Cognitive slowing: tasks that used to feel automatic now require more conscious effort.

Tchen et al. (2003) documented cognitive function alongside menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer, demonstrating the measurable cognitive impact of chemotherapy-induced menopause. While this is a specific context, it established that abrupt estrogen withdrawal produces documented cognitive effects.

The mechanism isn't fully resolved, but estrogen supports neuronal glucose metabolism, and its decline may affect brain energy use, particularly in regions involved in memory and executive function. A current Phase 2 trial (NCT05664477) is investigating whether PhytoSERM supplementation can prevent menopause-associated decline in brain metabolism using 18F-FDG PET imaging to measure glucose uptake.

Brain fog usually improves once hormones stabilize, either naturally after menopause or with HRT.

---

Musculoskeletal Symptoms: Joint Pain, Muscle Loss, Bone Density

These are the symptoms that tend to come on gradually and get attributed to "just getting older" before anyone looks at hormones.

Joint pain and stiffness: estrogen has anti-inflammatory effects. When it drops, inflammation in joints increases. Women often notice their knees, hips, and shoulders aching more. In the global MENQOL survey, aching in muscles and joints was reported by 68% of US postmenopausal women, nearly as prevalent as hot flashes (Nappi et al., 2021).

Muscle loss: estrogen plays a role in maintaining muscle protein synthesis. Menopause accelerates the loss of lean mass that typically begins in midlife. Strength training partially offsets this, but the hormonal environment still matters.

Bone density loss: this is a long-term consequence, not an acute symptom, but it starts during perimenopause. Estrogen is essential for maintaining bone density; its decline accelerates bone resorption. Women with surgical menopause (ovary removal) are at particularly high risk because the drop is abrupt rather than gradual.

Decreased strength and exercise performance: even women who maintain their training schedules often notice their lifts stagnating or declining, slower recovery, and less muscle definition.

---

Skin, Hair, and Body Composition Changes

Estrogen receptors are present in skin cells. When estrogen drops, skin changes, and the changes are more than cosmetic.

Dry skin: reduced sebum production and decreased skin moisture. The skin barrier becomes less effective.

Thinning skin: skin literally becomes thinner and more prone to bruising or injury. Collagen production declines.

Hair loss: the same hormonal shift that causes thinning on the scalp can cause increased growth on the chin and upper lip. Estrogen helps maintain the anagen (growth) phase of hair; its decline shortens that phase.

Changes in body fat distribution: visceral fat accumulation in the abdomen increases during menopause, independent of total caloric intake. This isn't willpower. The hormonal environment changes where your body stores fat. Szmuilowicz et al. (2009) reviewed this in Nature Reviews Endocrinology, noting that while aging accounts for some body composition change, menopause itself has an independent effect on visceral fat and insulin sensitivity.

Acne: some women experience adult acne during perimenopause due to testosterone becoming relatively dominant as estrogen drops.

Collagen loss: estimated at 30% in the first five years after menopause, contributing to both skin changes and joint changes.

---

Cardiovascular and Metabolic Changes

This category isn't usually on the "symptoms" list, because these are risks, not immediate experiences. But they're relevant to why menopause management matters beyond comfort.

Estrogen has cardioprotective effects. It improves lipid profiles, reduces arterial stiffness, and has anti-inflammatory properties. After menopause, cardiovascular disease risk rises.

The HERS trial (Shlipak et al., 2000) demonstrated the relationship between hormone therapy, lipoprotein(a) levels, and coronary heart disease events in postmenopausal women with existing coronary artery disease. A French study of 1,684 women (Trémollieres et al., 1999) found higher prevalence of hypertension and hypercholesterolemia in postmenopausal compared to perimenopausal women, even after controlling for age.

Palpitations: as noted, often related to vasomotor changes rather than true arrhythmia, but worth evaluating.

Elevated cholesterol: LDL tends to rise and HDL tends to fall during the transition.

Increased diabetes risk: postmenopausal hormone therapy may actually decrease type 2 diabetes risk, according to a review in Nature Reviews Endocrinology (Szmuilowicz et al., 2009).

Weight gain: particularly visceral fat, with metabolic consequences beyond aesthetics.

---

The Full 34+ Menopause Symptoms List

Here's the complete picture, organized by system:

Vasomotor

1. Hot flashes
2. Night sweats
3. Palpitations / racing heart
4. Flushing

Sleep and Fatigue 5. Insomnia 6. Difficulty falling asleep 7. Difficulty staying asleep 8. Fatigue and low energy 9. Restless legs

Psychological 10. Mood swings 11. Irritability and anger 12. Anxiety (new or worsened) 13. Depression 14. Crying spells / emotional lability 15. Panic attacks 16. Low motivation and apathy

Cognitive 17. Brain fog 18. Memory lapses (short-term) 19. Word retrieval problems 20. Difficulty concentrating

Urogenital 21. Vaginal dryness 22. Vaginal atrophy / GSM 23. Painful intercourse (dyspareunia) 24. Decreased libido 25. Urinary urgency 26. Urinary incontinence 27. Recurrent UTIs 28. Pelvic floor changes

Musculoskeletal 29. Joint pain and stiffness 30. Muscle aches and loss 31. Decreased bone density (osteoporosis risk) 32. Reduced exercise performance / recovery

Skin and Hair 33. Dry, thinning skin 34. Hair loss (scalp) 35. Increased facial hair 36. Adult acne 37. Collagen loss

Other 38. Bloating and digestive changes 39. Headaches / migraines (can worsen during perimenopause) 40. Tinnitus (ringing in ears, less common but reported) 41. Dry eyes and mouth 42. Irregular periods / spotting (perimenopause sign) 43. Breast tenderness

---

Which Symptoms HRT Actually Helps (and Which It Doesn't)

This is what most articles don't tell you clearly. Not all menopause symptoms have the same response to hormone therapy.

Strong HRT response:

• Hot flashes and night sweats (this is what HRT was designed for)
• Sleep disruption (often improves once vasomotor symptoms resolve)
• Vaginal dryness, atrophy, and associated sexual symptoms
• Urinary urgency and frequency related to GSM
• Mood changes driven by estrogen fluctuation
• Bone density loss prevention

Moderate or partial HRT response:

• Brain fog (often improves, though the evidence is more variable)
• Fatigue (improves when sleep improves, but some women need other interventions)
• Joint pain (may improve with anti-inflammatory effect of estrogen)
• Skin changes (some improvement in collagen and hydration)
• Low libido (estrogen helps the physical barriers; testosterone may be needed additionally)

Limited HRT response:

• Hair loss (hormones may slow it, but rarely reverse established loss)
• Weight distribution changes (lifestyle and strength training still required)
• Palpitations not driven by vasomotor activity (need cardiac evaluation)
• Already-established bone loss (HRT prevents, doesn't significantly reverse)

Crandall et al. (2023) in JAMA confirms that estrogen is first-line for vasomotor and GSM symptoms, with nonhormonal options (paroxetine, venlafaxine) as alternatives for women who can't use hormones.

---

The WHI Study: What Actually Happened and Why It Still Matters

If you've ever had a doctor say "I can't prescribe HRT, it causes breast cancer and heart disease." That came from the Women's Health Initiative study results from 2002. Here's what the study actually showed and why most physicians now believe the interpretation was overstated.

The WHI enrolled predominantly older women (average age 63) who were more than 10 years past menopause, and used a specific formulation: oral conjugated equine estrogens plus medroxyprogesterone acetate (synthetic progestin). The results showed a small increased risk of breast cancer and cardiovascular events.

The problem: that formulation and that age group don't represent the typical perimenopausal or newly postmenopausal woman seeking symptom relief. The WHI results were misapplied to younger women in the menopausal transition, leading to a massive drop in HRT prescribing and years of undertreated symptoms.

Current clinical understanding:

• The timing hypothesis (also called the "window of opportunity") suggests HRT started within 10 years of menopause or before age 60 has a favorable cardiovascular risk profile, which differs from what was seen in older WHI participants
• Transdermal estrogen doesn't carry the same blood clot risk as oral estrogen
• Micronized progesterone (bioidentical) has a better safety profile than medroxyprogesterone acetate
• The absolute risk increase for breast cancer from the WHI was small (8 additional cases per 10,000 women per year), and the study was in a specific population with a specific formulation

The Nurses' Health Study (Grodstein, Manson, and Stampfer, 2001) showed that women who used hormone therapy before their initial coronary disease event had different outcomes than those who started after, supporting the importance of timing.

For most perimenopausal and early postmenopausal women, the current evidence supports that the benefits of HRT for symptom relief outweigh the risks. This is now the position of the North American Menopause Society, the British Menopause Society, and the Endocrine Society.

---

Menopause Age: When to Expect It

The average age of natural menopause in the US is 51. Most women reach menopause somewhere between 45 and 55. Before 40 is considered premature ovarian insufficiency (POI), a separate condition. After 55 is late menopause.

Perimenopause typically starts 4-10 years before the final menstrual period, though 2-3 years is common for the most symptomatic phase. The hormonal fluctuations during perimenopause can actually be more dramatic than postmenopause, because estrogen is swinging rather than steadily declining.

Factors that affect menopause age include genetics, smoking (smokers tend to reach menopause 1-2 years earlier), surgical history (removal of ovaries triggers immediate surgical menopause), and race/ethnicity.

If you're in your early 40s and having irregular periods plus symptoms: that's perimenopause until proven otherwise. You don't need to be "officially" in menopause for your symptoms to be real and treatable.

---

The "Normal Labs" Problem

One of the most common experiences in menopause communities: you go to the doctor with debilitating symptoms, they run labs, and FSH or estradiol comes back "normal." You leave without answers.

Here's the clinical reality: hormone levels during perimenopause fluctuate wildly. A single blood draw can completely miss the dysregulation you're experiencing. FSH rises on average during the transition, but one normal reading doesn't mean your estrogen isn't swinging dramatically day to day.

"But your blood results say your hormones are normal." This is the experience described by women on r/Menopause and r/Perimenopause constantly (community data, 2024-2025). The disconnect between lab values and lived symptoms is a known gap in standard primary care.

Treatment decisions during perimenopause should be driven by symptoms, not a single hormone panel. Current clinical guidelines support symptom-based treatment initiation.

---

Cost, Coverage, and How to Access HRT

HRT comes in multiple forms: pills, patches, gels, vaginal creams and rings, and pellets. Costs vary considerably.

Out-of-pocket estimates (monthly):

• Oral estrogen: $20-80/month generic
• Estrogen patch (e.g., generic estradiol): $30-100/month
• Vaginal estrogen cream: $30-90/month generic
• Compounded bioidentical hormones: $50-200/month depending on formulation
• Progesterone (micronized/Prometrium): $20-70/month generic

Insurance coverage: Most standard HRT formulations have generics that insurance covers with a prescription. The variable piece is often the progesterone. Compounded hormones are generally not covered by insurance and are out-of-pocket.

Labs: Your initial evaluation should include FSH, LH, estradiol, testosterone (total and free), SHBG, and a basic metabolic panel. Depending on your history, a lipid panel, thyroid panel, and bone density scan (DEXA) may also be appropriate.

At HEXIS, your consultation starts with a full hormone panel. No guesswork. Your provider evaluates your labs in the context of your symptoms, discusses all treatment options, and builds a protocol that fits your actual numbers and health history. Telehealth is available across our licensed states.

Learn more about HRT for women at HEXIS and what perimenopause symptoms overlap with menopause.

---

Frequently Asked Questions

What are the first signs of menopause?

Irregular periods are usually the earliest sign, followed by vasomotor symptoms, specifically hot flashes or night sweats. Mood changes, sleep disruption, and vaginal dryness often appear during perimenopause before the final menstrual period. If you're in your mid-to-late 40s with changing cycles and new symptoms, perimenopause is the likely explanation.

How many symptoms of menopause are there?

Clinical literature documents 34 or more distinct menopause symptoms across six body systems: vasomotor, sleep/fatigue, psychological, cognitive, urogenital, musculoskeletal, and skin/hair. The number varies by how finely symptoms are categorized. The Menopause Rating Scale (Heinemann et al., 2004) covers 11 core domains; real-world experience often involves 15-20 simultaneous symptoms at peak perimenopause.

Can menopause cause anxiety and depression?

Yes. Estrogen affects serotonin and dopamine pathways. Freeman et al. (2004) followed 436 women for four years and documented increased risk of depressive symptoms during the menopausal transition, independent of prior depression history, sleep, and other factors. Anxiety can emerge or worsen during perimenopause even in women who've never had an anxiety disorder. Both can respond to HRT, particularly if they're hormonally driven.

Does menopause brain fog go away?

For most women, yes. Cognitive symptoms (difficulty concentrating, memory lapses, word retrieval problems) tend to improve once hormone levels stabilize, either naturally in postmenopause or with hormone therapy. The transition period is when symptoms are most pronounced because of the hormonal volatility.

Is it safe to take HRT?

For most women under 60 who start HRT within 10 years of menopause, the benefits outweigh the risks. The 2002 WHI study scared an entire generation off HRT with findings that were misapplied to younger women using a formulation that's rarely used today. Current formulations (especially transdermal estradiol and micronized progesterone) have better safety profiles. Women with a personal history of certain cancers, clotting disorders, or specific cardiovascular conditions may need to avoid systemic hormones, though local vaginal estrogen remains appropriate for most of these women. Discuss your individual risk profile with a provider. Read our complete breakdown of hormone replacement therapy.

---

If This List Looks Familiar, There's a Next Step

Recognizing your symptoms is half of it. The other half is finding a provider who actually takes them seriously and knows how to treat them.

Your HEXIS provider starts with a full hormone panel, reviews your symptom picture, and builds a protocol around your actual numbers. Not a generic checklist. Menopause symptoms are treatable. Suffering through them isn't a requirement.

Schedule a consultation and get your labs evaluated by a licensed provider who specializes in hormone optimization for women.

---